Thomas Gayner - Markel Group Inc.
Holding/activity history for Teva Pharmaceutical Industries Ltd. (TEVA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2014 Q4 | 0 | 0.00 | Sell 100.00% | 0.70 | SEC | ||
| 2014 Q3 | 444,000 | 0.70 | Reduce 36.02% | 0.39 | $53.75 | $23,865,000 | SEC |
| 2014 Q2 | 694,000 | 1.08 | $52.42 | $36,379,000 | SEC | ||
| 2014 Q1 | 694,000 | 1.17 | Reduce 0.84% | <0.01 | $52.84 | $36,671,000 | SEC |
| 2013 Q4 | 699,900 | 0.92 | Reduce 0.01% | <0.01 | $40.08 | $28,052,000 | SEC |
| 2013 Q3 | 700,000 | 0.94 | Add 0.14% | <0.01 | $37.78 | $26,446,000 | SEC |
| 2013 Q2 | 699,000 | 1.03 | Add 5.33% | 0.05 | $39.20 | $27,401,000 | SEC |
| 2013 Q1 | 663,600 | 1.02 | Add 3.03% | 0.03 | $39.68 | $26,332,000 | SEC |
| 2012 Q4 | 644,100 | 1.06 | Add 8.12% | 0.08 | $37.34 | $24,051,000 | SEC |
| 2012 Q3 | 595,700 | 1.16 | Add 7.62% | 0.08 | $41.41 | $24,668,000 | SEC |
| 2012 Q2 | 553,500 | 1.09 | Add 3.15% | 0.03 | $39.44 | $21,830,000 | SEC |
| 2012 Q1 | 536,600 | 1.20 | Add 14.63% | 0.15 | $45.06 | $24,179,000 | SEC |
| 2011 Q4 | 468,100 | 1.09 | Add 38.41% | 0.30 | $40.36 | $18,893,000 | SEC |
| 2011 Q3 | 338,200 | 0.81 | Add 34.15% | 0.21 | $37.22 | $12,588,000 | SEC |
| 2011 Q2 | 252,100 | 0.69 | Add 76.79% | 0.30 | $48.22 | $12,156,000 | SEC |
| 2011 Q1 | 142,600 | 0.42 | Add 17.27% | 0.06 | $50.17 | $7,154,000 | SEC |
| 2010 Q4 | 121,600 | 0.38 | Add 35.87% | 0.10 | $52.13 | $6,339,000 | SEC |
| 2010 Q3 | 89,500 | 0.31 | Add 48.67% | 0.10 | $52.75 | $4,721,000 | SEC |
| 2010 Q2 | 60,200 | 0.23 | Buy | 0.23 | $51.99 | $3,130,000 | SEC |